A detailed history of Legal & General Group PLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 287,544 shares of LAB stock, worth $454,319. This represents 0.0% of its overall portfolio holdings.

Number of Shares
287,544
Previous 287,544 -0.0%
Holding current value
$454,319
Previous $554,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.42 - $2.35 $357 - $592
-252 Reduced 0.09%
287,544 $554,000
Q2 2024

Aug 14, 2024

BUY
$1.65 - $2.92 $156,797 - $277,484
95,029 Added 49.3%
287,796 $509,000
Q1 2024

May 14, 2024

BUY
$1.87 - $2.78 $360,474 - $535,892
192,767 New
192,767 $522,000
Q3 2022

Nov 14, 2022

SELL
$1.1 - $2.06 $64,033 - $119,916
-58,212 Reduced 98.21%
1,061 $1,000
Q2 2022

Aug 22, 2022

BUY
$1.6 - $3.99 $51,612 - $128,709
32,258 Added 119.41%
59,273 $95,000
Q3 2021

Nov 15, 2021

BUY
$5.5 - $7.41 $78,991 - $106,422
14,362 Added 113.51%
27,015 $178,000
Q2 2021

Aug 12, 2021

SELL
$4.35 - $6.35 $1,770 - $2,584
-407 Reduced 3.12%
12,653 $78,000
Q1 2021

May 17, 2021

SELL
$3.94 - $7.09 $7,348 - $13,222
-1,865 Reduced 12.5%
13,060 $59,000
Q4 2020

Feb 12, 2021

BUY
$5.45 - $8.65 $37,844 - $60,065
6,944 Added 87.01%
14,925 $90,000
Q3 2020

Nov 13, 2020

SELL
$4.34 - $11.43 $12,577 - $33,124
-2,898 Reduced 26.64%
7,981 $59,000
Q2 2020

Aug 14, 2020

SELL
$1.85 - $5.29 $8,693 - $24,857
-4,699 Reduced 30.16%
10,879 $43,000
Q1 2020

May 14, 2020

SELL
$1.24 - $4.35 $13,512 - $47,401
-10,897 Reduced 41.16%
15,578 $40,000
Q4 2019

Feb 13, 2020

BUY
$2.3 - $5.12 $16,339 - $36,372
7,104 Added 36.67%
26,475 $91,000
Q3 2019

Nov 13, 2019

BUY
$4.63 - $12.15 $18,918 - $49,644
4,086 Added 26.73%
19,371 $89,000
Q2 2019

Aug 14, 2019

BUY
$11.49 - $14.17 $113,808 - $140,353
9,905 Added 184.11%
15,285 $189,000
Q1 2019

May 15, 2019

BUY
$8.47 - $14.36 $7,961 - $13,498
940 Added 21.17%
5,380 $72,000
Q4 2018

Feb 15, 2019

BUY
$7.18 - $8.83 $5,858 - $7,205
816 Added 22.52%
4,440 $38,000
Q2 2018

Aug 10, 2018

SELL
$4.86 - $6.24 $15,576 - $19,999
-3,205 Reduced 46.93%
3,624 $22,000
Q1 2018

May 17, 2018

SELL
$5.75 - $7.97 $15,766 - $21,853
-2,742 Reduced 28.65%
6,829 $40,000
Q4 2017

Feb 13, 2018

BUY
$4.46 - $6.45 $42,686 - $61,732
9,571
9,571 $57,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $124M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.